

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 9.78340163 |
| 2 | DNA deamination (GO:0045006) | 7.66117287 |
| 3 | transcription from mitochondrial promoter (GO:0006390) | 7.34485189 |
| 4 | proline metabolic process (GO:0006560) | 7.34038750 |
| 5 | replication fork processing (GO:0031297) | 6.93483591 |
| 6 | positive regulation of protein homooligomerization (GO:0032464) | 6.00825857 |
| 7 | oxidative demethylation (GO:0070989) | 5.70454015 |
| 8 | embryonic process involved in female pregnancy (GO:0060136) | 5.68573153 |
| 9 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 5.60411149 |
| 10 | regulation of protein homooligomerization (GO:0032462) | 5.51588951 |
| 11 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.36915011 |
| 12 | cullin deneddylation (GO:0010388) | 5.33805801 |
| 13 | viral mRNA export from host cell nucleus (GO:0046784) | 5.22528299 |
| 14 | DNA strand renaturation (GO:0000733) | 5.08032493 |
| 15 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.99604899 |
| 16 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.99604899 |
| 17 | protein deneddylation (GO:0000338) | 4.90022898 |
| 18 | formation of translation preinitiation complex (GO:0001731) | 4.61436006 |
| 19 | negative regulation of JAK-STAT cascade (GO:0046426) | 4.60388297 |
| 20 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.59704899 |
| 21 | poly(A)+ mRNA export from nucleus (GO:0016973) | 4.58607239 |
| 22 | mitochondrial DNA metabolic process (GO:0032042) | 4.46640843 |
| 23 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.37403219 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.36362757 |
| 25 | GDP-mannose metabolic process (GO:0019673) | 4.33720436 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.24587654 |
| 27 | negative regulation of protein oligomerization (GO:0032460) | 4.23752552 |
| 28 | base-excision repair, AP site formation (GO:0006285) | 4.18938791 |
| 29 | DNA double-strand break processing (GO:0000729) | 4.10173256 |
| 30 | regulation of integrin activation (GO:0033623) | 4.10096139 |
| 31 | establishment of apical/basal cell polarity (GO:0035089) | 4.06838782 |
| 32 | base-excision repair (GO:0006284) | 4.05070707 |
| 33 | DNA integration (GO:0015074) | 4.01143971 |
| 34 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.97498696 |
| 35 | negative regulation of B cell apoptotic process (GO:0002903) | 3.95905814 |
| 36 | mRNA cleavage (GO:0006379) | 3.87587580 |
| 37 | regulation of translational fidelity (GO:0006450) | 3.84381290 |
| 38 | maturation of 5.8S rRNA (GO:0000460) | 3.76709485 |
| 39 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.76515706 |
| 40 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.73997902 |
| 41 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.73241060 |
| 42 | establishment of monopolar cell polarity (GO:0061162) | 3.73241060 |
| 43 | positive regulation of DNA repair (GO:0045739) | 3.71523805 |
| 44 | tolerance induction (GO:0002507) | 3.71405278 |
| 45 | cellular response to ATP (GO:0071318) | 3.69071335 |
| 46 | negative regulation of cell cycle arrest (GO:0071157) | 3.65670983 |
| 47 | protein neddylation (GO:0045116) | 3.65626623 |
| 48 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.59612901 |
| 49 | negative regulation of heart rate (GO:0010459) | 3.53228001 |
| 50 | mitochondrial RNA metabolic process (GO:0000959) | 3.48981688 |
| 51 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.48718602 |
| 52 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.46703786 |
| 53 | positive regulation of developmental pigmentation (GO:0048087) | 3.44610402 |
| 54 | oxidative phosphorylation (GO:0006119) | 3.41120874 |
| 55 | iron-sulfur cluster assembly (GO:0016226) | 3.39861602 |
| 56 | metallo-sulfur cluster assembly (GO:0031163) | 3.39861602 |
| 57 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.39410790 |
| 58 | regulation of B cell apoptotic process (GO:0002902) | 3.38732550 |
| 59 | telomere maintenance via recombination (GO:0000722) | 3.38420721 |
| 60 | proteasome assembly (GO:0043248) | 3.37391178 |
| 61 | DNA strand elongation (GO:0022616) | 3.36997821 |
| 62 | termination of RNA polymerase II transcription (GO:0006369) | 3.36071476 |
| 63 | DNA ligation (GO:0006266) | 3.33839844 |
| 64 | non-recombinational repair (GO:0000726) | 3.32950686 |
| 65 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.32950686 |
| 66 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.31018483 |
| 67 | regulation of cilium movement (GO:0003352) | 3.30549730 |
| 68 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.28302129 |
| 69 | DNA demethylation (GO:0080111) | 3.27979665 |
| 70 | synaptic vesicle endocytosis (GO:0048488) | 3.27273884 |
| 71 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.26741525 |
| 72 | protein insertion into membrane (GO:0051205) | 3.25206800 |
| 73 | regulation of protein oligomerization (GO:0032459) | 3.25112397 |
| 74 | negative regulation of appetite (GO:0032099) | 3.22361566 |
| 75 | negative regulation of response to food (GO:0032096) | 3.22361566 |
| 76 | nucleotide salvage (GO:0043173) | 3.21046077 |
| 77 | organelle membrane fusion (GO:0090174) | 3.19439793 |
| 78 | nuclear envelope reassembly (GO:0031468) | 3.18830472 |
| 79 | mitotic nuclear envelope reassembly (GO:0007084) | 3.18830472 |
| 80 | purine nucleotide salvage (GO:0032261) | 3.17240126 |
| 81 | kinetochore assembly (GO:0051382) | 3.14356758 |
| 82 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.13916895 |
| 83 | cellular response to zinc ion (GO:0071294) | 3.13543304 |
| 84 | actin filament depolymerization (GO:0030042) | 3.13493314 |
| 85 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.12878963 |
| 86 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.11283219 |
| 87 | negative regulation of mRNA processing (GO:0050686) | 3.10777642 |
| 88 | G1 DNA damage checkpoint (GO:0044783) | 3.09927529 |
| 89 | regulation of mitochondrial depolarization (GO:0051900) | 3.06726244 |
| 90 | convergent extension (GO:0060026) | 3.03500101 |
| 91 | glial cell migration (GO:0008347) | 3.02346350 |
| 92 | histone arginine methylation (GO:0034969) | 3.01265049 |
| 93 | amino sugar catabolic process (GO:0046348) | 3.00870125 |
| 94 | histone H4-K12 acetylation (GO:0043983) | 3.00663979 |
| 95 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.95704526 |
| 96 | protein maturation by protein folding (GO:0022417) | 2.94634528 |
| 97 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.93969962 |
| 98 | mRNA polyadenylation (GO:0006378) | 2.93669614 |
| 99 | pseudouridine synthesis (GO:0001522) | 2.93009892 |
| 100 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.92658641 |
| 101 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.92658641 |
| 102 | mitotic G1/S transition checkpoint (GO:0044819) | 2.91833381 |
| 103 | telomere maintenance via telomere lengthening (GO:0010833) | 2.90086436 |
| 104 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.88008592 |
| 105 | NIK/NF-kappaB signaling (GO:0038061) | 2.87443765 |
| 106 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.87371155 |
| 107 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.86728557 |
| 108 | N-acetylneuraminate metabolic process (GO:0006054) | 2.85982985 |
| 109 | neuromuscular process controlling posture (GO:0050884) | 2.85722173 |
| 110 | type B pancreatic cell proliferation (GO:0044342) | 2.83191289 |
| 111 | lipopolysaccharide metabolic process (GO:0008653) | 2.83046145 |
| 112 | negative regulation of RNA splicing (GO:0033119) | 2.81815150 |
| 113 | auditory receptor cell stereocilium organization (GO:0060088) | 2.81311745 |
| 114 | cellular zinc ion homeostasis (GO:0006882) | 2.79520599 |
| 115 | mitochondrial DNA replication (GO:0006264) | 2.78920286 |
| 116 | positive regulation of protein oligomerization (GO:0032461) | 2.78333801 |
| 117 | nodal signaling pathway (GO:0038092) | 2.77738906 |
| 118 | lysosome localization (GO:0032418) | 2.77681200 |
| 119 | immunoglobulin mediated immune response (GO:0016064) | 2.75905687 |
| 120 | single strand break repair (GO:0000012) | 2.73557447 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 2.73451739 |
| 122 | embryonic placenta development (GO:0001892) | 2.73154919 |
| 123 | viral protein processing (GO:0019082) | 2.73104798 |
| 124 | signal complex assembly (GO:0007172) | 2.71716687 |
| 125 | succinate metabolic process (GO:0006105) | 2.71637636 |
| 126 | positive regulation of circadian rhythm (GO:0042753) | 2.70680507 |
| 127 | positive regulation of receptor recycling (GO:0001921) | 2.70617322 |
| 128 | negative regulation of Ras GTPase activity (GO:0034261) | 2.70504178 |
| 129 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69779928 |
| 130 | ribosome biogenesis (GO:0042254) | 2.69359780 |
| 131 | mitotic recombination (GO:0006312) | 2.69292247 |
| 132 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.68847820 |
| 133 | virion assembly (GO:0019068) | 2.67741004 |
| 134 | L-methionine salvage (GO:0071267) | 2.65471918 |
| 135 | L-methionine biosynthetic process (GO:0071265) | 2.65471918 |
| 136 | amino acid salvage (GO:0043102) | 2.65471918 |
| 137 | phagosome maturation (GO:0090382) | 2.64659831 |
| 138 | regulation of defense response to virus by virus (GO:0050690) | 2.64519171 |
| 139 | positive regulation of mitochondrial fission (GO:0090141) | 2.63989188 |
| 140 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.63613437 |
| 141 | protein targeting to mitochondrion (GO:0006626) | 2.63275137 |
| 142 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.62428348 |
| 143 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.61008188 |
| 144 | positive regulation of TOR signaling (GO:0032008) | 2.60189460 |
| 145 | cellular metabolic compound salvage (GO:0043094) | 2.58257932 |
| 146 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.57276819 |
| 147 | negative regulation of cell killing (GO:0031342) | 2.57276819 |
| 148 | deoxyribonucleotide catabolic process (GO:0009264) | 2.56782761 |
| 149 | mitochondrial calcium ion transport (GO:0006851) | 2.56595865 |
| 150 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.54181771 |
| 151 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.53346508 |
| 152 | pyrimidine-containing compound salvage (GO:0008655) | 2.50549311 |
| 153 | pyrimidine nucleoside salvage (GO:0043097) | 2.50549311 |
| 154 | establishment of protein localization to mitochondrion (GO:0072655) | 2.47393572 |
| 155 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.46477952 |
| 156 | fatty acid elongation (GO:0030497) | 2.46163613 |
| 157 | mast cell degranulation (GO:0043303) | 2.45102675 |
| 158 | mast cell activation involved in immune response (GO:0002279) | 2.45102675 |
| 159 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.45008741 |
| 160 | pentose-phosphate shunt (GO:0006098) | 2.44807649 |
| 161 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.43897175 |
| 162 | regulation of autophagic vacuole assembly (GO:2000785) | 2.42429603 |
| 163 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.42175034 |
| 164 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.41368787 |
| 165 | zinc ion homeostasis (GO:0055069) | 2.40494844 |
| 166 | deoxyribose phosphate catabolic process (GO:0046386) | 2.40132471 |
| 167 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.39885043 |
| 168 | peptidyl-arginine methylation (GO:0018216) | 2.39574143 |
| 169 | peptidyl-arginine N-methylation (GO:0035246) | 2.39574143 |
| 170 | GMP metabolic process (GO:0046037) | 2.35890957 |
| 171 | response to misfolded protein (GO:0051788) | 2.33605989 |
| 172 | nucleoside salvage (GO:0043174) | 2.32692243 |
| 173 | positive regulation of B cell differentiation (GO:0045579) | 2.32277641 |
| 174 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.30685028 |
| 175 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.30685028 |
| 176 | synaptic vesicle exocytosis (GO:0016079) | 2.29699675 |
| 177 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.28733282 |
| 178 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.28733282 |
| 179 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.28733282 |
| 180 | transferrin transport (GO:0033572) | 2.28689383 |
| 181 | negative regulation of innate immune response (GO:0045824) | 2.27646452 |
| 182 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.27374583 |
| 183 | autophagic vacuole fusion (GO:0000046) | 2.27015199 |
| 184 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.26600420 |
| 185 | cytochrome complex assembly (GO:0017004) | 2.26001126 |
| 186 | leukocyte degranulation (GO:0043299) | 2.23925986 |
| 187 | regulation of vacuole organization (GO:0044088) | 2.23622031 |
| 188 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.22980993 |
| 189 | regulation of regulatory T cell differentiation (GO:0045589) | 2.22900305 |
| 190 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.22829578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.35909085 |
| 2 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 3.27848176 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.25539890 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.21957248 |
| 5 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 3.03399913 |
| 6 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.93286594 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.78589389 |
| 8 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.59335149 |
| 9 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.52431115 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.49760820 |
| 11 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.49706431 |
| 12 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.45247629 |
| 13 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.33240329 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.30850350 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.25891781 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.24800487 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.20627781 |
| 18 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13642816 |
| 19 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.13074886 |
| 20 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.12477453 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.11503488 |
| 22 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.10932142 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.09844659 |
| 24 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.08140245 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06928321 |
| 26 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.02682449 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.02101240 |
| 28 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.98678112 |
| 29 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.98678112 |
| 30 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.98678112 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.96022083 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93172424 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90997322 |
| 34 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.89936318 |
| 35 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.88239993 |
| 36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.87928653 |
| 37 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.85194663 |
| 38 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.85172660 |
| 39 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.85103057 |
| 40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.84790744 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.82881537 |
| 42 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.81112431 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79871909 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78907936 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.75371102 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75168361 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75166167 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73674655 |
| 49 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.72698768 |
| 50 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.71877280 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70424167 |
| 52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69776356 |
| 53 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.68595577 |
| 54 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.67048030 |
| 55 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66095941 |
| 56 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.66079600 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65782332 |
| 58 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.65595573 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.64677473 |
| 60 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64533385 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.64512748 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64492583 |
| 63 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.61486616 |
| 64 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.60383696 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.59618144 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58086097 |
| 67 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.57964105 |
| 68 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.57456994 |
| 69 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.56809155 |
| 70 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.55544857 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53914017 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.53272232 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.53015781 |
| 74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.52939743 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52317766 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51542231 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51283404 |
| 78 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.47846755 |
| 79 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47542020 |
| 80 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.46439530 |
| 81 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.45287022 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44451076 |
| 83 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.42977356 |
| 84 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.42772367 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.41248277 |
| 86 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40644338 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40261593 |
| 88 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.39580468 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 1.38661397 |
| 90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.38297898 |
| 91 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37181515 |
| 92 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.35864757 |
| 93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33555786 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33431910 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32207305 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31978953 |
| 97 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.31730476 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31601058 |
| 99 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.31200452 |
| 100 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.30894208 |
| 101 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.30871819 |
| 102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.30385416 |
| 103 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30173800 |
| 104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.28277110 |
| 105 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27541207 |
| 106 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27260696 |
| 107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26831760 |
| 108 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.26676379 |
| 109 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.26449738 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.26170400 |
| 111 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.25424209 |
| 112 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.25421527 |
| 113 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.24978782 |
| 114 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.24893973 |
| 115 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.24483974 |
| 116 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24394291 |
| 117 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.24269204 |
| 118 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23465465 |
| 119 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.22302484 |
| 120 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21257633 |
| 121 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.21116248 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20829044 |
| 123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20675315 |
| 124 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.19740465 |
| 125 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19635581 |
| 126 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.19587858 |
| 127 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.19531806 |
| 128 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19347756 |
| 129 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19115073 |
| 130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18748492 |
| 131 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.18713478 |
| 132 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17943571 |
| 133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17494311 |
| 134 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.16372211 |
| 135 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.15416987 |
| 136 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15320206 |
| 137 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14307808 |
| 138 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13706315 |
| 139 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13409590 |
| 140 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.11319361 |
| 141 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.10193918 |
| 142 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.10063277 |
| 143 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08872721 |
| 144 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07584248 |
| 145 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07532313 |
| 146 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06513992 |
| 147 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05751621 |
| 148 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.05642321 |
| 149 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.04889660 |
| 150 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04666814 |
| 151 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04607580 |
| 152 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01739667 |
| 153 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01710712 |
| 154 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01540006 |
| 155 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.00543876 |
| 156 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.99287357 |
| 157 | MYC_22102868_ChIP-Seq_BL_Human | 0.99276164 |
| 158 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.98495114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 5.37798665 |
| 2 | MP0005171_absent_coat_pigmentation | 4.58499325 |
| 3 | MP0010030_abnormal_orbit_morphology | 3.52233122 |
| 4 | MP0004233_abnormal_muscle_weight | 3.18490312 |
| 5 | MP0009278_abnormal_bone_marrow | 2.93897915 |
| 6 | MP0002653_abnormal_ependyma_morphology | 2.88034397 |
| 7 | MP0003436_decreased_susceptibility_to | 2.68096017 |
| 8 | MP0009840_abnormal_foam_cell | 2.53869549 |
| 9 | MP0008995_early_reproductive_senescence | 2.53598765 |
| 10 | MP0003724_increased_susceptibility_to | 2.43902195 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.36681287 |
| 12 | MP0003011_delayed_dark_adaptation | 2.36407520 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.33007598 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.24610876 |
| 15 | MP0006072_abnormal_retinal_apoptosis | 2.22670733 |
| 16 | MP0008260_abnormal_autophagy | 2.19468447 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.17650748 |
| 18 | MP0003890_abnormal_embryonic-extraembry | 2.17345150 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.13703975 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.12035256 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.08096252 |
| 22 | MP0004133_heterotaxia | 2.07924842 |
| 23 | MP0005671_abnormal_response_to | 2.07071488 |
| 24 | MP0010094_abnormal_chromosome_stability | 2.06131668 |
| 25 | MP0003303_peritoneal_inflammation | 2.04767373 |
| 26 | MP0002009_preneoplasia | 2.03242303 |
| 27 | MP0004142_abnormal_muscle_tone | 2.02695188 |
| 28 | MP0006082_CNS_inflammation | 1.98601089 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 1.98179838 |
| 30 | MP0003786_premature_aging | 1.94942113 |
| 31 | MP0008058_abnormal_DNA_repair | 1.94037988 |
| 32 | MP0003880_abnormal_central_pattern | 1.92533779 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.88085809 |
| 34 | MP0003763_abnormal_thymus_physiology | 1.87909374 |
| 35 | MP0003119_abnormal_digestive_system | 1.85258029 |
| 36 | MP0009046_muscle_twitch | 1.84707795 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.83482653 |
| 38 | MP0009785_altered_susceptibility_to | 1.82588737 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.79970682 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.79970682 |
| 41 | MP0005025_abnormal_response_to | 1.78945134 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.77109490 |
| 43 | MP0004147_increased_porphyrin_level | 1.76440569 |
| 44 | MP0000604_amyloidosis | 1.74153970 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.73681301 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.72940125 |
| 47 | MP0008932_abnormal_embryonic_tissue | 1.66566778 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.66484106 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.63831523 |
| 50 | MP0000015_abnormal_ear_pigmentation | 1.63811734 |
| 51 | MP0003329_amyloid_beta_deposits | 1.63385472 |
| 52 | MP0002064_seizures | 1.61207313 |
| 53 | MP0002723_abnormal_immune_serum | 1.59529117 |
| 54 | MP0001800_abnormal_humoral_immune | 1.59443153 |
| 55 | MP0002063_abnormal_learning/memory/cond | 1.58027377 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.56040024 |
| 57 | MP0003075_altered_response_to | 1.53381644 |
| 58 | MP0001819_abnormal_immune_cell | 1.53032125 |
| 59 | MP0002249_abnormal_larynx_morphology | 1.51772099 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.51410581 |
| 61 | MP0002419_abnormal_innate_immunity | 1.50645535 |
| 62 | MP0003635_abnormal_synaptic_transmissio | 1.48162870 |
| 63 | MP0005451_abnormal_body_composition | 1.45959219 |
| 64 | MP0000358_abnormal_cell_content/ | 1.45142931 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.43853050 |
| 66 | MP0001529_abnormal_vocalization | 1.41791777 |
| 67 | MP0003283_abnormal_digestive_organ | 1.38777998 |
| 68 | MP0001790_abnormal_immune_system | 1.38680240 |
| 69 | MP0005387_immune_system_phenotype | 1.38680240 |
| 70 | MP0002282_abnormal_trachea_morphology | 1.36385026 |
| 71 | MP0000639_abnormal_adrenal_gland | 1.35865012 |
| 72 | MP0002733_abnormal_thermal_nociception | 1.35347142 |
| 73 | MP0005646_abnormal_pituitary_gland | 1.34812074 |
| 74 | MP0002398_abnormal_bone_marrow | 1.33910438 |
| 75 | MP0001970_abnormal_pain_threshold | 1.28870771 |
| 76 | MP0009764_decreased_sensitivity_to | 1.27991737 |
| 77 | MP0001533_abnormal_skeleton_physiology | 1.26253161 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25503129 |
| 79 | MP0000716_abnormal_immune_system | 1.24683237 |
| 80 | MP0002722_abnormal_immune_system | 1.22879097 |
| 81 | MP0003300_gastrointestinal_ulcer | 1.20729361 |
| 82 | MP0002254_reproductive_system_inflammat | 1.18418482 |
| 83 | MP0000343_altered_response_to | 1.18049841 |
| 84 | MP0000955_abnormal_spinal_cord | 1.17733145 |
| 85 | MP0002269_muscular_atrophy | 1.17610558 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.17562030 |
| 87 | MP0000685_abnormal_immune_system | 1.15896405 |
| 88 | MP0002429_abnormal_blood_cell | 1.15461747 |
| 89 | MP0001697_abnormal_embryo_size | 1.13656299 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 1.13583831 |
| 91 | MP0003111_abnormal_nucleus_morphology | 1.12821178 |
| 92 | MP0000689_abnormal_spleen_morphology | 1.10284510 |
| 93 | MP0008469_abnormal_protein_level | 1.10248318 |
| 94 | MP0000703_abnormal_thymus_morphology | 1.10174411 |
| 95 | MP0005266_abnormal_metabolism | 1.09509980 |
| 96 | MP0003186_abnormal_redox_activity | 1.07634262 |
| 97 | MP0002751_abnormal_autonomic_nervous | 1.07387345 |
| 98 | MP0001905_abnormal_dopamine_level | 1.07151046 |
| 99 | MP0004510_myositis | 1.06463776 |
| 100 | MP0002272_abnormal_nervous_system | 1.06002692 |
| 101 | MP0002405_respiratory_system_inflammati | 1.04501030 |
| 102 | MP0001986_abnormal_taste_sensitivity | 1.04248784 |
| 103 | MP0005408_hypopigmentation | 1.03975665 |
| 104 | MP0009745_abnormal_behavioral_response | 1.03429662 |
| 105 | MP0004811_abnormal_neuron_physiology | 1.03329069 |
| 106 | MP0001293_anophthalmia | 1.02994987 |
| 107 | MP0002084_abnormal_developmental_patter | 1.01923273 |
| 108 | MP0003866_abnormal_defecation | 1.01458207 |
| 109 | MP0005253_abnormal_eye_physiology | 1.01337561 |
| 110 | MP0003137_abnormal_impulse_conducting | 1.00146059 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.99376737 |
| 112 | MP0002736_abnormal_nociception_after | 0.99156706 |
| 113 | MP0000778_abnormal_nervous_system | 0.99013684 |
| 114 | MP0003077_abnormal_cell_cycle | 0.97678712 |
| 115 | MP0002138_abnormal_hepatobiliary_system | 0.97577327 |
| 116 | MP0003718_maternal_effect | 0.95536076 |
| 117 | MP0002102_abnormal_ear_morphology | 0.95470891 |
| 118 | MP0008874_decreased_physiological_sensi | 0.94187462 |
| 119 | MP0001968_abnormal_touch/_nociception | 0.93864210 |
| 120 | MP0006292_abnormal_olfactory_placode | 0.92269372 |
| 121 | MP0002085_abnormal_embryonic_tissue | 0.91543834 |
| 122 | MP0009763_increased_sensitivity_to | 0.91435452 |
| 123 | MP0005166_decreased_susceptibility_to | 0.91387252 |
| 124 | MP0000049_abnormal_middle_ear | 0.88754307 |
| 125 | MP0000747_muscle_weakness | 0.88418836 |
| 126 | MP0000681_abnormal_thyroid_gland | 0.87564742 |
| 127 | MP0000462_abnormal_digestive_system | 0.87188815 |
| 128 | MP0005535_abnormal_body_temperature | 0.86648868 |
| 129 | MP0002066_abnormal_motor_capabilities/c | 0.86004549 |
| 130 | MP0008569_lethality_at_weaning | 0.85857001 |
| 131 | MP0002184_abnormal_innervation | 0.85041587 |
| 132 | MP0002086_abnormal_extraembryonic_tissu | 0.84814577 |
| 133 | MP0000470_abnormal_stomach_morphology | 0.84133344 |
| 134 | MP0003693_abnormal_embryo_hatching | 0.83924997 |
| 135 | MP0000858_altered_metastatic_potential | 0.83583070 |
| 136 | MP0003656_abnormal_erythrocyte_physiolo | 0.83521642 |
| 137 | MP0001873_stomach_inflammation | 0.83328623 |
| 138 | MP0001340_abnormal_eyelid_morphology | 0.83069145 |
| 139 | MP0002067_abnormal_sensory_capabilities | 0.82983018 |
| 140 | MP0005423_abnormal_somatic_nervous | 0.82189337 |
| 141 | MP0005058_abnormal_lysosome_morphology | 0.82104622 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.81708646 |
| 143 | MP0002114_abnormal_axial_skeleton | 0.81657670 |
| 144 | MP0000490_abnormal_crypts_of | 0.81550710 |
| 145 | MP0002909_abnormal_adrenal_gland | 0.80760187 |
| 146 | MP0008007_abnormal_cellular_replicative | 0.80002772 |
| 147 | MP0002111_abnormal_tail_morphology | 0.78484562 |
| 148 | MP0000750_abnormal_muscle_regeneration | 0.77148081 |
| 149 | MP0002882_abnormal_neuron_morphology | 0.76657247 |
| 150 | MP0006036_abnormal_mitochondrial_physio | 0.76550836 |
| 151 | MP0002932_abnormal_joint_morphology | 0.76255687 |
| 152 | MP0002822_catalepsy | 0.75730326 |
| 153 | MP0000579_abnormal_nail_morphology | 0.74990363 |
| 154 | MP0003943_abnormal_hepatobiliary_system | 0.74580680 |
| 155 | MP0000371_diluted_coat_color | 0.74534338 |
| 156 | MP0004947_skin_inflammation | 0.74049662 |
| 157 | MP0004924_abnormal_behavior | 0.73658138 |
| 158 | MP0005386_behavior/neurological_phenoty | 0.73658138 |
| 159 | MP0001186_pigmentation_phenotype | 0.73260424 |
| 160 | MP0001853_heart_inflammation | 0.72926897 |
| 161 | MP0001502_abnormal_circadian_rhythm | 0.72913452 |
| 162 | MP0004197_abnormal_fetal_growth/weight/ | 0.72709755 |
| 163 | MP0000013_abnormal_adipose_tissue | 0.72632042 |
| 164 | MP0002693_abnormal_pancreas_physiology | 0.72356968 |
| 165 | MP0002152_abnormal_brain_morphology | 0.72170111 |
| 166 | MP0002075_abnormal_coat/hair_pigmentati | 0.72135198 |
| 167 | MP0008873_increased_physiological_sensi | 0.71279800 |
| 168 | MP0003122_maternal_imprinting | 0.70798900 |
| 169 | MP0008004_abnormal_stomach_pH | 0.70775168 |
| 170 | MP0000350_abnormal_cell_proliferation | 0.70101857 |
| 171 | MP0004134_abnormal_chest_morphology | 0.69460851 |
| 172 | MP0010768_mortality/aging | 0.69272838 |
| 173 | MP0001764_abnormal_homeostasis | 0.68845011 |
| 174 | MP0002970_abnormal_white_adipose | 0.68102956 |
| 175 | MP0002132_abnormal_respiratory_system | 0.67773375 |
| 176 | MP0002080_prenatal_lethality | 0.67159771 |
| 177 | MP0000631_abnormal_neuroendocrine_gland | 0.66644174 |
| 178 | MP0002163_abnormal_gland_morphology | 0.66381536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Annular pancreas (HP:0001734) | 4.58840060 |
| 2 | Increased IgM level (HP:0003496) | 4.51408684 |
| 3 | Rib fusion (HP:0000902) | 4.50431025 |
| 4 | Concave nail (HP:0001598) | 4.37572951 |
| 5 | Rectal fistula (HP:0100590) | 4.15002785 |
| 6 | Rectovaginal fistula (HP:0000143) | 4.15002785 |
| 7 | Poikiloderma (HP:0001029) | 4.12958190 |
| 8 | Tongue fasciculations (HP:0001308) | 3.99025826 |
| 9 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.83147508 |
| 10 | Facial hemangioma (HP:0000329) | 3.68647151 |
| 11 | Vaginal fistula (HP:0004320) | 3.61301055 |
| 12 | Intestinal fistula (HP:0100819) | 3.56648068 |
| 13 | Muscle fibrillation (HP:0010546) | 3.47620873 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.46393964 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42454700 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42454700 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42454700 |
| 18 | Increased muscle lipid content (HP:0009058) | 3.38186810 |
| 19 | Increased intramyocellular lipid droplets (HP:0012240) | 3.33872597 |
| 20 | Atonic seizures (HP:0010819) | 3.32618992 |
| 21 | Intestinal atresia (HP:0011100) | 3.30421135 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.28631365 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.19975549 |
| 24 | Pustule (HP:0200039) | 3.19142073 |
| 25 | Anteriorly placed anus (HP:0001545) | 3.16841275 |
| 26 | Petechiae (HP:0000967) | 3.12396238 |
| 27 | Orthostatic hypotension (HP:0001278) | 3.06678892 |
| 28 | Hepatic necrosis (HP:0002605) | 3.05800606 |
| 29 | Progressive neurologic deterioration (HP:0002344) | 3.00809566 |
| 30 | Broad alveolar ridges (HP:0000187) | 3.00400053 |
| 31 | IgM deficiency (HP:0002850) | 2.98944231 |
| 32 | Turricephaly (HP:0000262) | 2.94635847 |
| 33 | B lymphocytopenia (HP:0010976) | 2.94356226 |
| 34 | Diaphragmatic weakness (HP:0009113) | 2.93920186 |
| 35 | Male infertility (HP:0003251) | 2.92365143 |
| 36 | Ragged-red muscle fibers (HP:0003200) | 2.92264787 |
| 37 | Abnormality of the aortic arch (HP:0012303) | 2.92017653 |
| 38 | Dysautonomia (HP:0002459) | 2.89835467 |
| 39 | Mitochondrial inheritance (HP:0001427) | 2.89744019 |
| 40 | Abnormality of the labia minora (HP:0012880) | 2.87850317 |
| 41 | Retinal dysplasia (HP:0007973) | 2.87577504 |
| 42 | Epileptic encephalopathy (HP:0200134) | 2.87249791 |
| 43 | Stomatitis (HP:0010280) | 2.87142628 |
| 44 | Abnormal gallbladder physiology (HP:0012438) | 2.86321489 |
| 45 | Cholecystitis (HP:0001082) | 2.86321489 |
| 46 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.86138474 |
| 47 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.86138474 |
| 48 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.85992552 |
| 49 | Delusions (HP:0000746) | 2.85866738 |
| 50 | Narrow nasal bridge (HP:0000446) | 2.83127813 |
| 51 | Short humerus (HP:0005792) | 2.79381271 |
| 52 | Coronal craniosynostosis (HP:0004440) | 2.77466432 |
| 53 | CNS hypomyelination (HP:0003429) | 2.77126005 |
| 54 | Abnormality of male internal genitalia (HP:0000022) | 2.76262575 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.74198733 |
| 56 | Congenital hip dislocation (HP:0001374) | 2.71957173 |
| 57 | Gait imbalance (HP:0002141) | 2.71428531 |
| 58 | Vertebral hypoplasia (HP:0008417) | 2.66998563 |
| 59 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.66998563 |
| 60 | Congenital primary aphakia (HP:0007707) | 2.66825753 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.66597785 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.65684867 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65684867 |
| 64 | Alacrima (HP:0000522) | 2.65366119 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.64228485 |
| 66 | Absent radius (HP:0003974) | 2.63515146 |
| 67 | Pheochromocytoma (HP:0002666) | 2.63430665 |
| 68 | Poor suck (HP:0002033) | 2.63424578 |
| 69 | Large for gestational age (HP:0001520) | 2.63289269 |
| 70 | Alopecia of scalp (HP:0002293) | 2.62184750 |
| 71 | Emotional lability (HP:0000712) | 2.61174782 |
| 72 | Clumsiness (HP:0002312) | 2.59247662 |
| 73 | Absent thumb (HP:0009777) | 2.58877039 |
| 74 | Increased CSF lactate (HP:0002490) | 2.58327822 |
| 75 | Type 2 muscle fiber atrophy (HP:0003554) | 2.57528684 |
| 76 | Premature skin wrinkling (HP:0100678) | 2.57024733 |
| 77 | Muscle fiber atrophy (HP:0100295) | 2.56744343 |
| 78 | Hypokinesia (HP:0002375) | 2.54634529 |
| 79 | Visual hallucinations (HP:0002367) | 2.53277157 |
| 80 | Aplasia involving forearm bones (HP:0009822) | 2.52884132 |
| 81 | Absent forearm bone (HP:0003953) | 2.52884132 |
| 82 | Microvesicular hepatic steatosis (HP:0001414) | 2.51613339 |
| 83 | Premature graying of hair (HP:0002216) | 2.47845118 |
| 84 | Cerebral hypomyelination (HP:0006808) | 2.47158165 |
| 85 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.45515455 |
| 86 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.45515455 |
| 87 | 3-Methylglutaconic aciduria (HP:0003535) | 2.44615383 |
| 88 | Growth hormone excess (HP:0000845) | 2.42695314 |
| 89 | Exertional dyspnea (HP:0002875) | 2.42240171 |
| 90 | Hypochromic microcytic anemia (HP:0004840) | 2.39601107 |
| 91 | Short chin (HP:0000331) | 2.39124734 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 2.39037253 |
| 93 | Patellar aplasia (HP:0006443) | 2.38447430 |
| 94 | Opisthotonus (HP:0002179) | 2.37190211 |
| 95 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.36507804 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.36349910 |
| 97 | Choanal stenosis (HP:0000452) | 2.34646970 |
| 98 | Bifid uvula (HP:0000193) | 2.33217158 |
| 99 | Joint stiffness (HP:0001387) | 2.32854107 |
| 100 | Squamous cell carcinoma (HP:0002860) | 2.31294512 |
| 101 | Supranuclear gaze palsy (HP:0000605) | 2.30865833 |
| 102 | Mediastinal lymphadenopathy (HP:0100721) | 2.30583407 |
| 103 | Medial flaring of the eyebrow (HP:0010747) | 2.29570141 |
| 104 | Ulnar bowing (HP:0003031) | 2.29545422 |
| 105 | Unsteady gait (HP:0002317) | 2.28899544 |
| 106 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27823027 |
| 107 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27823027 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27823027 |
| 109 | Loss of speech (HP:0002371) | 2.26647545 |
| 110 | Neoplasm of head and neck (HP:0012288) | 2.26279865 |
| 111 | Esophageal neoplasm (HP:0100751) | 2.26279865 |
| 112 | Dysostosis multiplex (HP:0000943) | 2.26002427 |
| 113 | Focal motor seizures (HP:0011153) | 2.24850465 |
| 114 | Hepatosplenomegaly (HP:0001433) | 2.24714438 |
| 115 | Abnormality of T cell physiology (HP:0011840) | 2.23426148 |
| 116 | Redundant skin (HP:0001582) | 2.23143884 |
| 117 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.20949369 |
| 118 | Hamartoma (HP:0010566) | 2.20292467 |
| 119 | Acute necrotizing encephalopathy (HP:0006965) | 2.19905900 |
| 120 | Febrile seizures (HP:0002373) | 2.19157619 |
| 121 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.18677267 |
| 122 | Increased serum lactate (HP:0002151) | 2.18356264 |
| 123 | Decreased lacrimation (HP:0000633) | 2.17739738 |
| 124 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.15694987 |
| 125 | Hypotelorism (HP:0000601) | 2.15623640 |
| 126 | Recurrent abscess formation (HP:0002722) | 2.14831493 |
| 127 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.14762026 |
| 128 | Abnormal hemoglobin (HP:0011902) | 2.13804699 |
| 129 | Bulbar palsy (HP:0001283) | 2.13711093 |
| 130 | Purpura (HP:0000979) | 2.13161895 |
| 131 | Progressive microcephaly (HP:0000253) | 2.12441717 |
| 132 | Acute lymphatic leukemia (HP:0006721) | 2.12420247 |
| 133 | Acute encephalopathy (HP:0006846) | 2.11716829 |
| 134 | Abnormality of macrophages (HP:0004311) | 2.11546888 |
| 135 | Ankle clonus (HP:0011448) | 2.11278111 |
| 136 | Myokymia (HP:0002411) | 2.09403971 |
| 137 | Poor coordination (HP:0002370) | 2.08725070 |
| 138 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.08685703 |
| 139 | Diminished movement (HP:0002374) | 2.08459608 |
| 140 | Lactic acidosis (HP:0003128) | 2.07903121 |
| 141 | Testicular atrophy (HP:0000029) | 2.06797040 |
| 142 | Spinal muscular atrophy (HP:0007269) | 2.05757357 |
| 143 | Gastrointestinal stroma tumor (HP:0100723) | 2.03682783 |
| 144 | CNS demyelination (HP:0007305) | 2.03682166 |
| 145 | Capillary hemangiomas (HP:0005306) | 2.03574516 |
| 146 | Autoamputation (HP:0001218) | 2.02081798 |
| 147 | Severe combined immunodeficiency (HP:0004430) | 2.01621712 |
| 148 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.01341234 |
| 149 | Recurrent bacterial skin infections (HP:0005406) | 2.00449834 |
| 150 | Renal Fanconi syndrome (HP:0001994) | 2.00338722 |
| 151 | Hepatocellular necrosis (HP:0001404) | 1.99274191 |
| 152 | Exercise intolerance (HP:0003546) | 1.98538174 |
| 153 | Absence seizures (HP:0002121) | 1.98506378 |
| 154 | Degeneration of anterior horn cells (HP:0002398) | 1.98294631 |
| 155 | Abnormality of the anterior horn cell (HP:0006802) | 1.98294631 |
| 156 | Amelogenesis imperfecta (HP:0000705) | 1.98118945 |
| 157 | Hand muscle atrophy (HP:0009130) | 1.97694839 |
| 158 | Selective tooth agenesis (HP:0001592) | 1.97205328 |
| 159 | Myoclonus (HP:0001336) | 1.97082906 |
| 160 | Fetal akinesia sequence (HP:0001989) | 1.96150022 |
| 161 | IgG deficiency (HP:0004315) | 1.95696483 |
| 162 | Prolonged neonatal jaundice (HP:0006579) | 1.95275087 |
| 163 | Obstructive lung disease (HP:0006536) | 1.95201543 |
| 164 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95201543 |
| 165 | Thickened helices (HP:0000391) | 1.93853798 |
| 166 | Hypoplasia of the radius (HP:0002984) | 1.92349044 |
| 167 | Acute hepatic failure (HP:0006554) | 1.92101070 |
| 168 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91671861 |
| 169 | Cerebral palsy (HP:0100021) | 1.91082298 |
| 170 | Eczematoid dermatitis (HP:0000976) | 1.90786481 |
| 171 | Respiratory failure (HP:0002878) | 1.88864589 |
| 172 | Stridor (HP:0010307) | 1.88670898 |
| 173 | Albinism (HP:0001022) | 1.86516368 |
| 174 | Cholelithiasis (HP:0001081) | 1.86206996 |
| 175 | Progressive macrocephaly (HP:0004481) | 1.85215592 |
| 176 | Recurrent fungal infections (HP:0002841) | 1.84953563 |
| 177 | Posterior subcapsular cataract (HP:0007787) | 1.84705586 |
| 178 | Myositis (HP:0100614) | 1.83215995 |
| 179 | Severe visual impairment (HP:0001141) | 1.81618752 |
| 180 | J-shaped sella turcica (HP:0002680) | 1.80902851 |
| 181 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.80259742 |
| 182 | Abnormality of the gallbladder (HP:0005264) | 1.80142189 |
| 183 | Hypertensive crisis (HP:0100735) | 1.79755355 |
| 184 | Distal upper limb amyotrophy (HP:0007149) | 1.79537871 |
| 185 | Upper limb amyotrophy (HP:0009129) | 1.79537871 |
| 186 | Dicarboxylic aciduria (HP:0003215) | 1.78815124 |
| 187 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78815124 |
| 188 | Prolonged bleeding time (HP:0003010) | 1.78445364 |
| 189 | Personality changes (HP:0000751) | 1.78405904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 4.80181454 |
| 2 | MAP3K6 | 4.62319135 |
| 3 | MAPK15 | 4.09133184 |
| 4 | DDR2 | 4.04398984 |
| 5 | DAPK1 | 3.57906129 |
| 6 | NME2 | 3.55980243 |
| 7 | BCKDK | 3.45788329 |
| 8 | MAP3K11 | 3.45726183 |
| 9 | PINK1 | 3.10915522 |
| 10 | MATK | 2.72497204 |
| 11 | PIM2 | 2.68920678 |
| 12 | UHMK1 | 2.63316213 |
| 13 | FGR | 2.51659475 |
| 14 | TESK1 | 2.51516461 |
| 15 | AKT3 | 2.50790613 |
| 16 | YES1 | 2.47397922 |
| 17 | VRK2 | 2.39997375 |
| 18 | TYRO3 | 2.39660437 |
| 19 | MAP4K1 | 2.37646538 |
| 20 | ERN1 | 2.25095026 |
| 21 | IRAK3 | 2.03541689 |
| 22 | CDK19 | 1.91792162 |
| 23 | CSNK1G3 | 1.82634730 |
| 24 | CASK | 1.78926158 |
| 25 | PRPF4B | 1.78807422 |
| 26 | MAP3K12 | 1.75229641 |
| 27 | TAOK1 | 1.72585768 |
| 28 | LIMK1 | 1.71768097 |
| 29 | PRKD2 | 1.67136023 |
| 30 | MAP2K3 | 1.63507835 |
| 31 | PRKD3 | 1.63230927 |
| 32 | KDR | 1.56747755 |
| 33 | RIPK4 | 1.56552861 |
| 34 | SMG1 | 1.49526830 |
| 35 | MAPKAPK3 | 1.47420011 |
| 36 | CSNK1A1L | 1.45605948 |
| 37 | TBK1 | 1.44849317 |
| 38 | ACVR1B | 1.44093954 |
| 39 | MAP4K2 | 1.37837939 |
| 40 | BMX | 1.36562704 |
| 41 | CDK7 | 1.34340019 |
| 42 | MAP2K7 | 1.33921146 |
| 43 | CSK | 1.32902258 |
| 44 | BUB1 | 1.28597380 |
| 45 | PRKCI | 1.28203774 |
| 46 | ZAP70 | 1.27527176 |
| 47 | RPS6KC1 | 1.25302415 |
| 48 | RPS6KL1 | 1.25302415 |
| 49 | CSNK1G2 | 1.23104751 |
| 50 | GRK6 | 1.17797753 |
| 51 | PHKG2 | 1.16991664 |
| 52 | PHKG1 | 1.16991664 |
| 53 | TRIB3 | 1.15198188 |
| 54 | DYRK1B | 1.12021276 |
| 55 | ITK | 1.11438072 |
| 56 | RPS6KA6 | 1.08659070 |
| 57 | PDGFRA | 1.08592316 |
| 58 | LATS2 | 1.07470448 |
| 59 | EPHA4 | 1.06754653 |
| 60 | FES | 1.05965048 |
| 61 | TRIM28 | 1.04735754 |
| 62 | TXK | 1.00902348 |
| 63 | TYK2 | 1.00446017 |
| 64 | SIK3 | 1.00303386 |
| 65 | SYK | 0.98066681 |
| 66 | RAF1 | 0.96696268 |
| 67 | ABL2 | 0.95426896 |
| 68 | PAK4 | 0.94967315 |
| 69 | KIT | 0.94793288 |
| 70 | STK16 | 0.91439369 |
| 71 | MAP3K5 | 0.90907627 |
| 72 | CDK8 | 0.88635218 |
| 73 | PIM1 | 0.86737846 |
| 74 | CDC42BPA | 0.85881884 |
| 75 | EIF2AK1 | 0.85479735 |
| 76 | TEC | 0.84804030 |
| 77 | DYRK2 | 0.83307116 |
| 78 | CCNB1 | 0.80986149 |
| 79 | BTK | 0.80341313 |
| 80 | TAOK2 | 0.79573240 |
| 81 | IRAK4 | 0.78339660 |
| 82 | CHEK2 | 0.75464843 |
| 83 | BLK | 0.75408272 |
| 84 | EPHB1 | 0.74886709 |
| 85 | MAP3K13 | 0.74235827 |
| 86 | CAMK2B | 0.74175863 |
| 87 | PLK1 | 0.73282213 |
| 88 | SRPK1 | 0.71119798 |
| 89 | ILK | 0.70986733 |
| 90 | MUSK | 0.70910146 |
| 91 | MAP3K4 | 0.70398765 |
| 92 | DAPK3 | 0.69522570 |
| 93 | GRK5 | 0.68463571 |
| 94 | SIK1 | 0.68375161 |
| 95 | TRPM7 | 0.67030695 |
| 96 | WEE1 | 0.65357610 |
| 97 | MAP3K1 | 0.65206892 |
| 98 | ERBB3 | 0.65203932 |
| 99 | MAPK11 | 0.65058448 |
| 100 | MAP2K6 | 0.64705411 |
| 101 | CAMKK2 | 0.63723702 |
| 102 | DYRK3 | 0.62817437 |
| 103 | ARAF | 0.62635529 |
| 104 | NTRK2 | 0.62035696 |
| 105 | LCK | 0.62022511 |
| 106 | GSK3A | 0.61544854 |
| 107 | HCK | 0.58874899 |
| 108 | TSSK6 | 0.58732186 |
| 109 | AURKA | 0.58688470 |
| 110 | MAP3K3 | 0.58595338 |
| 111 | JAK3 | 0.58304989 |
| 112 | CAMK2A | 0.55883626 |
| 113 | MAP3K9 | 0.54017491 |
| 114 | CDK18 | 0.53918210 |
| 115 | RPS6KB1 | 0.53759486 |
| 116 | PTK2B | 0.52282991 |
| 117 | PRKCH | 0.52144714 |
| 118 | CDK11A | 0.50152691 |
| 119 | STK38 | 0.50044260 |
| 120 | CDK15 | 0.49506946 |
| 121 | CAMK2G | 0.49227942 |
| 122 | BRAF | 0.49164192 |
| 123 | NEK1 | 0.49036020 |
| 124 | TNK2 | 0.48850450 |
| 125 | LMTK2 | 0.47212331 |
| 126 | NTRK3 | 0.47162995 |
| 127 | CSNK2A1 | 0.47108731 |
| 128 | RPS6KA1 | 0.46570954 |
| 129 | CAMKK1 | 0.45535774 |
| 130 | MAPK4 | 0.45214215 |
| 131 | VRK1 | 0.44127220 |
| 132 | IKBKB | 0.42472821 |
| 133 | KSR2 | 0.41242615 |
| 134 | SIK2 | 0.39843718 |
| 135 | CDK14 | 0.39047686 |
| 136 | BRSK1 | 0.38945789 |
| 137 | ATR | 0.38883006 |
| 138 | IRAK2 | 0.38242017 |
| 139 | ZAK | 0.36866612 |
| 140 | PRKCQ | 0.36855736 |
| 141 | MINK1 | 0.36552210 |
| 142 | TESK2 | 0.36479115 |
| 143 | IKBKE | 0.36189635 |
| 144 | NME1 | 0.35415975 |
| 145 | PRKAA1 | 0.34998574 |
| 146 | MARK2 | 0.34431420 |
| 147 | LYN | 0.33615587 |
| 148 | MAP2K4 | 0.33536822 |
| 149 | MAPK13 | 0.33196780 |
| 150 | MAPK12 | 0.33149206 |
| 151 | CDK6 | 0.33114967 |
| 152 | CDK5 | 0.32595389 |
| 153 | MARK1 | 0.31988254 |
| 154 | CDK2 | 0.31606494 |
| 155 | MAPK3 | 0.30450176 |
| 156 | CSNK2A2 | 0.29722131 |
| 157 | HIPK2 | 0.28361630 |
| 158 | BRSK2 | 0.25772771 |
| 159 | CAMK2D | 0.23237526 |
| 160 | PAK6 | 0.21616701 |
| 161 | PRKCD | 0.21128644 |
| 162 | TNIK | 0.20908498 |
| 163 | CSNK1G1 | 0.20812612 |
| 164 | PRKCG | 0.20363200 |
| 165 | PAK1 | 0.19434959 |
| 166 | PLK2 | 0.18939050 |
| 167 | MAPK10 | 0.18903287 |
| 168 | DAPK2 | 0.18257020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 4.89522376 |
| 2 | Base excision repair_Homo sapiens_hsa03410 | 4.47940381 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.93836862 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.92284132 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.92523100 |
| 6 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.69678565 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.66100377 |
| 8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.46366575 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.26091426 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.22777225 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.18343353 |
| 12 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.15935139 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12341680 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.08769836 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.96669696 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.95725877 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.88547782 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.84571201 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.81830065 |
| 20 | RNA transport_Homo sapiens_hsa03013 | 1.81109486 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 1.80825223 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.76263414 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.68802591 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.67338457 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.66059268 |
| 26 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.64902070 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63091856 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.58592047 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.58501952 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.54103761 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.49676585 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.43621122 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.41422231 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.39890413 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.32196302 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32027749 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.31653609 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.28924394 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28907171 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27924811 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20457444 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20409377 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.18954898 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18196445 |
| 45 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.16092858 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14358517 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14318640 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13383027 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13183380 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12722464 |
| 51 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06385210 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 1.05530166 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.05116634 |
| 54 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.04527517 |
| 55 | Cell cycle_Homo sapiens_hsa04110 | 1.00740409 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00130281 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99101955 |
| 58 | Endocytosis_Homo sapiens_hsa04144 | 0.96708705 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.96601706 |
| 60 | GABAergic synapse_Homo sapiens_hsa04727 | 0.94755680 |
| 61 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92976586 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92405613 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91185746 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89353339 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88750495 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84894524 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.84426746 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.84328147 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84053331 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.83949433 |
| 71 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.82876036 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82731431 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.82299228 |
| 74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.79263492 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78646842 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.77201383 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73714403 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71182785 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.70753443 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70635111 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.70308261 |
| 82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69506679 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68350098 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.68271797 |
| 85 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.67713106 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67583261 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67519272 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.66897549 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66239475 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65012648 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64065358 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63968720 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60683054 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.59529179 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59259188 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.59164256 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59042841 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58489437 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58380492 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58068036 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57676620 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57264568 |
| 103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56970411 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55910472 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54445814 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54126664 |
| 107 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52672823 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.52671183 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51981768 |
| 110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50815200 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50806261 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.48827501 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.47688061 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47595396 |
| 115 | Purine metabolism_Homo sapiens_hsa00230 | 0.47379148 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47228325 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47021167 |
| 118 | Leishmaniasis_Homo sapiens_hsa05140 | 0.46733921 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45493878 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45238033 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44855229 |
| 122 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44537604 |
| 123 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43356886 |
| 124 | Protein export_Homo sapiens_hsa03060 | 0.43254851 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42011053 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41746817 |
| 127 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40790999 |
| 128 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39875162 |
| 129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38740053 |
| 130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38433574 |
| 131 | Hepatitis C_Homo sapiens_hsa05160 | 0.37077237 |
| 132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37025170 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32888515 |
| 134 | Hepatitis B_Homo sapiens_hsa05161 | 0.32770618 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32633290 |
| 136 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31466490 |
| 137 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.30464834 |
| 138 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.29856404 |
| 139 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29855545 |
| 140 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29695583 |
| 141 | Carbon metabolism_Homo sapiens_hsa01200 | 0.29643271 |
| 142 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29081669 |
| 143 | Long-term potentiation_Homo sapiens_hsa04720 | 0.28593621 |
| 144 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.28289066 |
| 145 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27320207 |
| 146 | Taste transduction_Homo sapiens_hsa04742 | 0.27106573 |
| 147 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26636423 |
| 148 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25895387 |
| 149 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.25624879 |
| 150 | Adherens junction_Homo sapiens_hsa04520 | 0.25596353 |
| 151 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23110919 |
| 152 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22830593 |
| 153 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.19398640 |
| 154 | Phototransduction_Homo sapiens_hsa04744 | 0.18226788 |
| 155 | Legionellosis_Homo sapiens_hsa05134 | 0.16973149 |

